Market Overview

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH)

0.02 -0.09 (-78.89%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/21/18Roth CapitalInitiates Coverage OnBuy10.0
12/29/16JefferiesDowngradesHold
12/29/16CitigroupDowngradesNeutral
9/17/15CitigroupInitiates Coverage onBuy15.0
5/12/15CitigroupUpgradesNeutral
3/17/15JefferiesMaintainsBuy12.0
3/28/13McNicoll Lewis VlakMaintainsBuy2.0
3/05/13JefferiesInitiates Coverage onBuy2.0
7/09/12Canaccord GenuityMaintainsBuy3.0
6/29/12Ascendiant CapitalDowngradesNeutral0.900

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter